v3.26.3
Stock Compensation Plan - SARs Activity (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Beginning Balance (in shares) 5,309,859 5,309,859    
Granted (in shares)   (2,573,953)    
Exercised (in shares)   (739,515)    
Ending Balance (in shares)   6,925,293    
Beginning Balance (in dollars per share) $ 5.54 $ 5.54    
Granted (in dollars per share)   7.29    
Exercised (in dollars per share)   2.78    
Ending Balance (in dollars per share)   $ 6.42    
Weighted Average Contractual Life (years)   4 years 11 months 1 day 2 years 9 months 10 days  
Intrinsic value   $ 24,078,000   $ 16,253,000
Stock Appreciation Rights (SARs)        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Beginning Balance (in shares) 2,650,000 2,650,000    
Granted (in shares)   0    
Exercised (in shares)   (500,000)    
Ending Balance (in shares)   2,150,000    
Beginning Balance (in dollars per share) $ 3.36 $ 3.36    
Granted (in dollars per share)   0    
Exercised (in dollars per share)   2.43    
Ending Balance (in dollars per share)   $ 3.63    
Weighted Average Contractual Life (years) 11 months 23 days 4 months 6 days    
Intrinsic value   $ 12,718,000   $ 11,752,000
Vested and Exercisable (in shares)   0    
Vested and Exercisable (in dollars per share)   $ 0